Skip to main content
Search

St. Paul's Hospital

2 related articles

Subscribe to updates
  1. After reviewing 922 citations, 41 international experts extended the acute exacerbation definition from IPF to all fibrotic interstitial lung diseases and proposed a new acute respiratory worsening framework

    An international multidisciplinary working group of 41 experts systematically reviewed 922 citations up to March 17, 2025, revised the 2016 acute exacerbation (AE) definition—previously limited to idiopathic pulmonary fibrosis (IPF)—into an AE-fILD definition applicable across all fibrotic interstitial lung diseases (anchored in diffuse alveolar damage with or without organizing pneumonia), proposed the broader concept of acute respiratory worsening (ARW) to capture acute deteriorations not attributable to DAD, and summarized evidence on epidemiology, risk factors, prognosis, and management while discussing AE as a clinical trial endpoint.

  2. Integrating AI quantitative CT, photon-counting CT, and FFR-CT brings coronary plaque burden and ischemia assessment into one CCTA workflow

    This review surveys recent advances in coronary CT angiography (CCTA) for coronary artery disease: AI-driven plaque and stenosis quantification can cut analysis time from over 25 minutes to typically under 60 seconds per case with correlation coefficients of 0.92-0.95 against intravascular ultrasound, photon-counting detector CT (PCD-CT) reduces calcium blooming at ultra-high resolution and reclassifies some cases to lower CAD-RADS categories, and FFR-CT adds noninvasive lesion-specific physiologic assessment, so that combining the three can support more refined risk stratification for major adverse cardiovascular events and preventive therapy decisions.

You’re all caught up